Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for Labeling of Raw Materials During Dispensing – V 2.0

Posted on By

Elixir Department: SOP for Labeling of Raw Materials During Dispensing – V 2.0

Standard Operating Procedure for Labeling of Raw Materials During Dispensing

Department Elixir Department
SOP No. SOP/ELX/006/2025
Supersedes SOP/ELX/006/2022
Page No. Page 1 of 8
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for proper and compliant labeling of raw materials at the time of dispensing for elixir manufacturing. This ensures traceability, prevents mix-ups, and supports GMP documentation practices.

2. Scope

This SOP applies to all raw materials, including active pharmaceutical ingredients (APIs), excipients, and solvents, that are dispensed for the manufacturing of elixirs in the Elixir Department.

3. Responsibilities

  • Dispensing Operator:
    • Ensure all containers are labeled immediately after dispensing.
  • Production Supervisor:
    • Verify correctness of label content and completeness.
  • QA Personnel:
    • Review and approve dispensed material labels before use in production.

4. Accountability

The Head of Quality Assurance and Head of Warehouse are accountable for ensuring that all dispensed materials are labeled as per regulatory and internal GMP requirements.

See also  Elixir Department: SOP for Use of Personal Protective Equipment (PPE) in Dispensing Room - V 2.0

5. Procedure

5.1 Label Format

  1. Use standardized label format as per
Annexure-1.
  • Labels must include the following information:
    • Material Name
    • Material Code
    • Batch Number of the Raw Material
    • Quantity Dispensed
    • Dispensed On (Date)
    • Dispensed By (Operator’s Name)
    • Checked By (Verifier’s Name)
    • Product Name & Batch Number for which the material is dispensed
    • Storage Condition (if applicable)
  • 5.2 Label Types

    1. Use different colored labels for different material types to minimize errors:
      • Yellow – APIs
      • Green – Excipients
      • Red – Solvents
    2. Labels must be non-removable, waterproof, and legible.

    5.3 Labeling Process

    1. Prepare labels using designated labeling software or pre-approved templates.
    2. After dispensing the material, affix the label to the dispensing container before transferring it to production.
    3. Labels should be affixed directly on the container body, not on the lid.
    4. In case of multiple containers for a single material, each container should be labeled individually.

    5.4 Verification

    1. The Production Supervisor shall verify:
      • Label content vs. batch records
      • Legibility and correctness of each label
    2. QA shall cross-check a sample of labels daily to ensure GMP compliance.

    5.5 Error Handling

    1. If an error is identified:
      • Do not overwrite the label.
      • Affix a new correct label after striking off the incorrect one with a single line.
      • Sign and date the correction.
      • Document the incident in the Label Correction Log (Annexure-2).

    5.6 Label Storage and Control

    1. Blank labels must be stored in a secure, controlled area.
    2. Maintain a log of label issuance and consumption.
    3. Scrap unused or rejected labels with QA oversight.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • GMP: Good Manufacturing Practice
    • API: Active Pharmaceutical Ingredient

    7. Documents

    1. Dispensing Label Format (Annexure-1)
    2. Label Correction Log (Annexure-2)
    3. Label Issuance Logbook

    8. References

    • 21 CFR Part 211 – Labeling Requirements
    • WHO GMP Guidelines – Materials Management

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Dispensing Label Format

    Material Name Code Batch No. Dispensed Qty Date Dispensed By Checked By Product Name & Batch No.
    Sucrose RM-SUC-001 SC0425B 15.0 kg 13/04/2025 Rajesh Kumar Sunita Reddy Elixir A / EA-0425-002

    Annexure-2: Label Correction Log

    Date Label No. Material Error Description Corrected By Remarks
    13/04/2025 LBL-00157 Sucrose Incorrect Batch No. Sunita Reddy New label affixed after correction

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    10/01/2022 1.0 Initial Version New SOP QA Head
    13/04/2025 2.0 Added label issuance controls and correction log Enhanced traceability QA Head
    See also  Elixir Department: SOP for Sampling of Raw Materials for Elixirs - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: API Manufacturing: SOP for Labeling of Recovered Solvents with Batch Information – V 2.0
    Next Post: Biosimilars: SOP for Stable Cell Line Development – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version